Single versus repeated intravenous oncolytic reovirus infusions: Implications for immune modulation and rationalised scheduling of therapy in hepatocellular carcinoma.

Scott KJ, West EJ, Brownlie RJ, Ismail F, Ralph C, Heineman T, Coffey M, Melcher AA, Taylor A, Papa S, Samson A.

Open source

DOI
10.1002/ijc.70386
Published
2026-02-16
Container
Int J Cancer
Publisher
Not recorded
Open access
yes

Credibility signals

limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1002/ijc.70386,
  title = {Single versus repeated intravenous oncolytic reovirus infusions: Implications for immune modulation and rationalised scheduling of therapy in hepatocellular carcinoma.},
  author = {Scott KJ and  West EJ and  Brownlie RJ and  Ismail F and  Ralph C and  Heineman T and  Coffey M and  Melcher AA and  Taylor A and  Papa S and  Samson A.},
  year = {2026},
  journal = {Int J Cancer},
  doi = {10.1002/ijc.70386},
  url = {https://doi.org/10.1002/ijc.70386}
}

RIS

TY  - JOUR
TI  - Single versus repeated intravenous oncolytic reovirus infusions: Implications for immune modulation and rationalised scheduling of therapy in hepatocellular carcinoma.
AU  - Scott KJ
AU  -  West EJ
AU  -  Brownlie RJ
AU  -  Ismail F
AU  -  Ralph C
AU  -  Heineman T
AU  -  Coffey M
AU  -  Melcher AA
AU  -  Taylor A
AU  -  Papa S
AU  -  Samson A.
PY  - 2026
JO  - Int J Cancer
DO  - 10.1002/ijc.70386
UR  - https://doi.org/10.1002/ijc.70386
ER  - 

APA

KJ, S., EJ, W., RJ, B., F, I., C, R., T, H., M, C., AA, M., A, T., S, P., & A., S. (2026). Single versus repeated intravenous oncolytic reovirus infusions: Implications for immune modulation and rationalised scheduling of therapy in hepatocellular carcinoma.. Int J Cancer. https://doi.org/10.1002/ijc.70386

Source records